Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Arbutus receives regulatory approval for phase Ia/Ib trial of AB-836 in chronic HBV infection

March 17, 2021

First patient dosed in phase I study of emricasan in mild symptomatic COVID-19

March 17, 2021

Moderna initiates phase I study of its next-generation COVID-19 vaccine, mRNA-1283

March 17, 2021

Moderna begins phase II/III pediatric trial of COVID-19 vaccine candidate mRNA-1273

March 16, 2021

Phase III evaluation starts of Medicago's COVID-19 vaccine candidate with GSK adjuvant

March 16, 2021

Phase I studies of hAd5 T-cell COVID-19 vaccine candidate meet safety requirements

March 16, 2021

AstraZeneca provides update on the safety of its COVID-19 vaccine

March 16, 2021

DC-402234 enters phase I clinical development in the U.S.

March 16, 2021

New diphtheria threat as antimicrobial resistance evolves

March 16, 2021

DARPins as promising mutation-resistant antivirals for potential SARS-CoV-2 treatment

March 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...